We examine how substance use disorder (SUD) treatment providers respond to private health insurance expansions induced by state equal coverage ('parity') laws for SUD treatment. We use data on the near universe of specialty SUD treatment providers in the United States between 1997 and 2010 in an...

We examine how substance use disorder (SUD) treatment providers respond to private insurance expansions induced by state equal coverage ('parity') laws for SUD treatment vis-à-vis general healthcare services. Economic theory suggests that such laws will lead to changes in provider behaviors. We...

We examine how substance use disorder (SUD) treatment providers respond to private health insurance expansions induced by state equal coverage ('parity') laws for SUD treatment. We use data on the near universe of specialty SUD treatment providers in the United States between 1997 and 2010 in an...

Versorgungsforschung, gesundheitsökonomische Evaluationen, GKV-Routinedaten, Versorgungsprozesse, Sekundärdaten. - Health services research, health economic evaluations, claims data, secondary data, health care process

We examine the early effects of U.S. state Medicaid expansions under the Affordable Care Act (ACA) on substance use disorder (SUD) treatment utilization. We couple administrative data on admissions to specialty SUD treatment and prescriptions for medications used to treat SUDs in outpatient...

We examine the effect of increasing the substance use disorder (SUD) treatment rate on reducing violent and property crime rates, based on county-level panels of SUD treatment and crime data between 2001 and 2008 across the United States. To address the potential endogeneity of the SUD treatment...

We provide the first evidence on the effects of expansions to private and public insurance programs on children’s use of specialty substance use disorder (SUD) treatment. We combine administrative government data over the period 1996 to 2017 with quasi-experimental differences-in-differences...